VEGFA and neoplasm: In addition to the inherent anti-angiogenesis mechanism, the inhibition of VEGF targets can indirectly activate the immune response to promote the tumor-killing and invasion effects of T cells, which can produce synergistic anti-tumor effects when combined with immunotherapy.